Application of a validated algorithm to estimate the effectiveness and cost of biologics for rheumatoid arthritis in the US pharmacy benefit manager context

by Wu N, Bhurke S, Shah N, Harrison DJ
Published 2015-05-01

Cost of tumor necrosis factor blockers per patient with rheumatoid arthritis in a multistate Medicaid population

by Bonafede M, Joseph GJ, Shah N, Princic N, Harrison DJ
Published 2014-09-01

Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors

by Hines DM, Rane P, Patel J, Harrison DJ, Wade RL
Published 2018-12-01

Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterole...

by Chen CC, Rane PB, Hines DM, Patel J, Harrison DJ, Wade RL
Published 2018-12-01